Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 509 articles:
HTML format



Single Articles


    June 2024
  1. MCCHORD J, Ong P
    Advancing precision medicine in INOCA research: The INOCA-IT registry.
    Int J Cardiol. 2024;404:131975.
    PubMed    


  2. SHIBA M, Kato T, Seko Y, Minamino-Muta E, et al
    Cobalt protoporphyrin promotes heme oxygenase 1 expression and ameliorates cardiac dysfunction in long-term fasting mice.
    Int J Cardiol. 2024;404:131972.
    PubMed     Abstract available


  3. STERPETTI AV, Gabriele R, Di Marzo L
    Sex disparities for clinical outcomes after percutaneous coronary intervention for acute coronary syndrome.
    Int J Cardiol. 2024;404:131937.
    PubMed    


  4. BACIGALUPI E, Pelliccia F, Zimarino M
    Diabetes mellitus and in-stent restenosis: A direct link or something more?
    Int J Cardiol. 2024;404:131922.
    PubMed    


  5. GOLINO M, Harding D, Del Buono MG, Fanti S, et al
    Innate and adaptive immunity in acute myocarditis.
    Int J Cardiol. 2024;404:131901.
    PubMed     Abstract available


    May 2024
  6. SAMPAIO RODRIGUES T, Narendren A, Cailes B, Lim RP, et al
    Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates.
    Int J Cardiol. 2024;403:131895.
    PubMed     Abstract available


  7. XU P, Cao Y, Zhang S, Liu X, et al
    The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome.
    Int J Cardiol. 2024;403:131887.
    PubMed     Abstract available


  8. DOUGHTY A, Keane G, Wadley AJ, Mahoney B, et al
    Plasma concentrations of thioredoxin, thioredoxin reductase and peroxiredoxin-4 can identify high risk patients and predict outcome in patients with acute coronary syndrome: A clinical observation.
    Int J Cardiol. 2024;403:131888.
    PubMed     Abstract available


  9. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
    Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
    Int J Cardiol. 2024;402:131889.
    PubMed     Abstract available


  10. OLSEN FJ, Smiseth OA, Biering-Sorensen T
    Improving post-MI risk stratification with pressure-strain loops: Work in progress.
    Int J Cardiol. 2024;402:131866.
    PubMed    


  11. DI VITO L, Di Giusto F, Grossi P
    Non-culprit plaque progression: What do we know?
    Int J Cardiol. 2024;402:131881.
    PubMed    


  12. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
    "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
    Int J Cardiol. 2024;402:131859.
    PubMed     Abstract available


  13. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
    Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
    Int J Cardiol. 2024;402:131819.
    PubMed     Abstract available


    April 2024
  14. ANDO G, Lombardo L, Alagna G, Micari A, et al
    Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: Filling gaps in evidence.
    Int J Cardiol. 2024;401:131893.
    PubMed     Abstract available


  15. BRUNO F, de Filippo O, Sardone A, Capranzano P, et al
    Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric study.
    Int J Cardiol. 2024;401:131861.
    PubMed     Abstract available


  16. HAN D, Hyun MC, Miller RJH, Gransar H, et al
    10-year experience of utilizing a stress-first SPECT myocardial perfusion imaging.
    Int J Cardiol. 2024;401:131863.
    PubMed     Abstract available


  17. TANNER R, Farhan S, Giustino G, Sartori S, et al
    Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.
    Int J Cardiol. 2024;401:131856.
    PubMed     Abstract available


  18. XIA B, Lu Y, Liang J, Li F, et al
    Association of GAL-8 promoter methylation levels with coronary plaque inflammation.
    Int J Cardiol. 2024;401:131782.
    PubMed     Abstract available


  19. RIEHLE C, Sieweke JT, Udesen NLJ, Helgestad OKL, et al
    Circulating biomarkers of the CS4P and CLIP scores are not altered in a pig model of acute cardiogenic shock and additional short-term circulatory support.
    Int J Cardiol. 2024;401:131699.
    PubMed     Abstract available


  20. WOLF S, Schievano E, Amidei CB, Kucher N, et al
    Mortality trend of ischemic heart disease (2008-2022): A retrospective analysis of epidemiological data.
    Int J Cardiol. 2024 Apr 12:132042. doi: 10.1016/j.ijcard.2024.132042.
    PubMed     Abstract available


  21. YANG J, Zhao Y, Wang J, Ma L, et al
    Current status of emergency medical service use in ST-segment elevation myocardial infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry.
    Int J Cardiol. 2024 Apr 11:132040. doi: 10.1016/j.ijcard.2024.132040.
    PubMed     Abstract available


  22. UELAND T, Butt N, Lekva T, Orn S, et al
    High dose statin treatment reduces circulating Dickkopf-1 following acute myocardial infarction.
    Int J Cardiol. 2024 Apr 9:132035. doi: 10.1016/j.ijcard.2024.132035.
    PubMed     Abstract available


  23. YILDIRIM M, Giannitsis E, Mueller-Hennessen M
    Reply to: Kavsak et al. The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Apr 6:132030. doi: 10.1016/j.ijcard.2024.132030.
    PubMed    


  24. ZHAO J, Wu T, Tan J, Chen Y, et al
    Pancoronary plaque characteristics in STEMI patients with rapid plaque progression: An optical coherence tomography study.
    Int J Cardiol. 2024;400:131821.
    PubMed     Abstract available


  25. KOTOKU N, Ninomiya K, Masuda S, Tsai TY, et al
    Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials.
    Int J Cardiol. 2024;400:131805.
    PubMed     Abstract available


  26. ORTEGA-PAZ L, Bonaca M, Angiolillo DJ
    Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies.
    Int J Cardiol. 2024;400:131803.
    PubMed    


  27. LIU Y, Cheng X, Qi B, Wang Y, et al
    Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3/NF-kappaB/HMGB-1 pathway.
    Int J Cardiol. 2024;400:131800.
    PubMed     Abstract available


  28. ABDELAZIZ A, Elsayed H, Atta K, Mechi A, et al
    A comprehensive guide on the optimal timing of PCI in the setting of acute coronary syndrome: An updated meta-analysis.
    Int J Cardiol. 2024;400:131774.
    PubMed     Abstract available


  29. YANG C, Sui YG, Shen JY, Guan CD, et al
    Diagnostic performance of ultrasonic flow ratio versus quantitative flow ratio for assessment of coronary stenosis.
    Int J Cardiol. 2024;400:131765.
    PubMed     Abstract available


  30. XIA B, Ding J, Li Q, Zheng K, et al
    Reply to "Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury".
    Int J Cardiol. 2024;400:131760.
    PubMed    


  31. IANNACCONE M, Franchin L
    Reply to: Supported PCI reduced one-year all-cause mortality compared to standard PCI?
    Int J Cardiol. 2024;400:131707.
    PubMed    


    March 2024
  32. CHENG Y, Zhang Q
    Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
    Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
    PubMed    


  33. PINGITORE A, Zhang C, Vassalle C, Ferragina P, et al
    Machine learning to identify a composite indicator to predict cardiac death in ischemic heart disease.
    Int J Cardiol. 2024 Mar 23:131981. doi: 10.1016/j.ijcard.2024.131981.
    PubMed     Abstract available


  34. ANTONOPOULOS AS, Simantiris S, Tousoulis D
    Thrombus aspiration in STEMI: Whom we aspire it may help?
    Int J Cardiol. 2024;399:131671.
    PubMed    


  35. YIFAN D, Yue M, Yubin Z, Jiapei G, et al
    The impact of early in-hospital use of PCSK9 inhibitors on cardiovascular outcomes in acute coronary syndrome patients: A systematic review and meta-analysis.
    Int J Cardiol. 2024;399:131775.
    PubMed     Abstract available


  36. CHAD T, Koulouroudias M, Layton GR, Fashina O, et al
    Frailty in acute coronary syndromes. A systematic review and narrative synthesis of frailty assessment tools and interventions from randomised controlled trials.
    Int J Cardiol. 2024;399:131764.
    PubMed     Abstract available


  37. VANDENBRIELE C, M'Pembele R, Dannenberg L, Metzen D, et al
    Heparin dosing in patients with Impella-supported cardiogenic shock.
    Int J Cardiol. 2024;399:131690.
    PubMed     Abstract available


  38. ZHENG Y, Wang L, Zhao Y, Gong H, et al
    Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte.
    Int J Cardiol. 2024;399:131688.
    PubMed     Abstract available


  39. HUANG M, Chen W, Liu D, Zheng M, et al
    Impact of post-dilatation on post-procedural physiology, microcirculatory resistance, and target vessel failure in STEMI patients undergoing PPCI: A single-center experience.
    Int J Cardiol. 2024;399:131685.
    PubMed     Abstract available


  40. NAKAO S, Ishihara T, Tsujimura T, Hata Y, et al
    Two-year real world clinical outcomes after intravascular imaging device guided percutaneous coronary intervention with ultrathin-strut biodegradable-polymer sirolimus-eluting stent.
    Int J Cardiol. 2024;399:131686.
    PubMed     Abstract available


  41. SKALIDIS I, Noirclerc N, Meier D, Luangphiphat W, et al
    Head-to-head comparison of two angiography-derived fractional flow reserve techniques in patients with high-risk acute coronary syndrome: A multicenter prospective study.
    Int J Cardiol. 2024;399:131663.
    PubMed     Abstract available


  42. NELLES G, Abdelwahed YS, Seppelt C, Meteva D, et al
    Cholesterol crystals at the culprit lesion in patients with acute coronary syndrome are associated with worse cardiovascular outcomes at two years follow up - results from the translational OPTICO-ACS study program.
    Int J Cardiol. 2024;399:131665.
    PubMed     Abstract available


  43. CANDREVA A, Gallo D, Munhoz D, Rizzini ML, et al
    Influence of intracoronary hemodynamic forces on atherosclerotic plaque phenotypes.
    Int J Cardiol. 2024;399:131668.
    PubMed     Abstract available


  44. MCCORD J
    Identification and definition of type 2 myocardial infarction: Where do we go from here?
    Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
    PubMed    


  45. GIACOBBE F, Giannino G, Annone U, Morena A, et al
    Impact of statin adherence and interruption within 6 months after ST-segment elevation myocardial infarction (STEMI): Results from the real-world regional registry FAST-STEMI.
    Int J Cardiol. 2024 Mar 2:131933. doi: 10.1016/j.ijcard.2024.131933.
    PubMed     Abstract available


  46. LI Q, Zhao L, Wang C, Liu Z, et al
    Loganin: A potential pharmacological agent for myocardial ischemia-reperfusion injury.
    Int J Cardiol. 2024;398:131650.
    PubMed    


  47. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    PubMed     Abstract available


    February 2024
  48. POVLSEN AL, Helgestad OKL, Josiassen J, Christensen S, et al
    Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis.
    Int J Cardiol. 2024 Feb 27:131910. doi: 10.1016/j.ijcard.2024.131910.
    PubMed     Abstract available


  49. KAVSAK PA, Worster A
    The clinical chemistry score (CCS) achieves the highest efficacy when assessed with the 99% sensitivity benchmark for myocardial infarction.
    Int J Cardiol. 2024 Feb 20:131898. doi: 10.1016/j.ijcard.2024.131898.
    PubMed    


  50. GONZALEZ-URBISTONDO F, Alperi A
    muQFR in ASET Pilot Studies: More Assets in the decision-making process for stable ischemic heart disease.
    Int J Cardiol. 2024 Feb 17:131880. doi: 10.1016/j.ijcard.2024.131880.
    PubMed    


  51. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    PubMed    


  52. KASSEM M, Ayala PL, Andric-Cancarevic T, Tajsic M, et al
    Copeptin for the differentiation of type 1 versus type 2 myocardial infarction or myocardial injury.
    Int J Cardiol. 2024 Feb 16:131879. doi: 10.1016/j.ijcard.2024.131879.
    PubMed     Abstract available


  53. XIAO Y, Liu C
    Supported PCI reduced one-year all-cause mortality compared to standard PCI?
    Int J Cardiol. 2024;397:131680.
    PubMed    


  54. FERLINI M, Munafo A, Varbella F, Delnevo F, et al
    Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry.
    Int J Cardiol. 2024;397:131659.
    PubMed     Abstract available


  55. DERIMAY F, Aminian A, Lattuca B, Souteyrand G, et al
    One year results of coronary bifurcation revascularization with the re-POT provisional sequential technique. The CABRIOLET registry.
    Int J Cardiol. 2024;397:131632.
    PubMed     Abstract available


  56. GARCIA-GUIMARAES M, Fernandez-Rodriguez D
    Spontaneous coronary artery dissection: A look back to build momentum.
    Int J Cardiol. 2024;397:131557.
    PubMed    


  57. PICA S, Crimi G, Castelvecchio S, Pazzanese V, et al
    Corrigendum to "Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study, Pica, Silvia et al." [International Journal of Cardiology, Volume 370, 8-17].
    Int J Cardiol. 2024 Feb 3:131824. doi: 10.1016/j.ijcard.2024.131824.
    PubMed    


  58. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
    Impact of sex on the assessment of the microvascular resistance reserve.
    Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
    PubMed     Abstract available


  59. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
    Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
    Int J Cardiol. 2024;396:131428.
    PubMed     Abstract available


  60. PIERI M, D'Andria Ursoleo J, Nardelli P, Ortalda A, et al
    Temporary mechanical circulatory support with Impella in cardiac surgery: A systematic review.
    Int J Cardiol. 2024;396:131418.
    PubMed     Abstract available


  61. RONG J, Gu N, Tian H, Shen Y, et al
    Association of the monocytes to high-density lipoprotein cholesterol ratio with in-stent neoatherosclerosis and plaque vulnerability: An optical coherence tomography study.
    Int J Cardiol. 2024;396:131417.
    PubMed     Abstract available


    January 2024
  62. FISZER R, Galeczka M, Smolka G, Sukiennik A, et al
    Multicentre short- and medium-term report on the device closure of a post-myocardial infarction ventricular septal rupture - In search of risk factors for early mortality.
    Int J Cardiol. 2024 Jan 31:131820. doi: 10.1016/j.ijcard.2024.131820.
    PubMed     Abstract available


  63. ANDERSEN PJ, Attar R, Jensen SE, Eftekhari A, et al
    Temporal trends in characteristics and outcomes after myocardial infarction in patients with and without peripheral artery disease - A Nationwide, register-based follow-up study.
    Int J Cardiol. 2024 Jan 25:131812. doi: 10.1016/j.ijcard.2024.131812.
    PubMed     Abstract available


  64. YILDIRIM M, Salbach C, Reich C, Milles BR, et al
    Comparison of the clinical chemistry score to other biomarker algorithms for rapid rule-out of acute myocardial infarction and risk stratification in patients with suspected acute coronary syndrome.
    Int J Cardiol. 2024 Jan 24:131815. doi: 10.1016/j.ijcard.2024.131815.
    PubMed     Abstract available


  65. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    PubMed     Abstract available


  66. NAGARAJA V, Lewis BR, Singh M
    Ten-year outcomes post percutaneous coronary intervention in cardiac transplant recipients.
    Int J Cardiol. 2024 Jan 24:131814. doi: 10.1016/j.ijcard.2024.131814.
    PubMed     Abstract available


  67. UKITA K, Egami Y, Nohara H, Kawanami S, et al
    Predictors of 30-day survival after emergent percutaneous coronary intervention following ventricular Tachyarrhythmias complicating acute myocardial infarction.
    Int J Cardiol. 2024 Jan 21:131806. doi: 10.1016/j.ijcard.2024.131806.
    PubMed     Abstract available


  68. SHALABY G, Sabri S, Alsilami ANS, Alhassani RY, et al
    Predictors of prolonged hospital stay and in-hospital mortality in female patients with acute myocardial infarction with specific reference to diabetes.
    Int J Cardiol. 2024 Jan 17:131785. doi: 10.1016/j.ijcard.2024.131785.
    PubMed     Abstract available


  69. HAO P, Feng S, Suo M, Wang S, et al
    Platelet to albumin ratio: A risk factor related to prognosis in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention.
    Int J Cardiol. 2024;395:131588.
    PubMed     Abstract available


  70. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
    Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
    Int J Cardiol. 2024;395:131578.
    PubMed     Abstract available


  71. HO AFW, Yau CE, Ho JS, Lim SH, et al
    Predictors of major adverse cardiac events among patients with chest pain and low HEART score in the emergency department.
    Int J Cardiol. 2024;395:131573.
    PubMed     Abstract available


  72. ELBADAWI A, Elgendy IY
    Revascularization strategies for non-culprit stenosis after acute coronary syndromes: The story so far.
    Int J Cardiol. 2024;395:131564.
    PubMed    


  73. XIA B, Ding J, Li Q, Zheng K, et al
    Loganin protects against myocardial ischemia-reperfusion injury by modulating oxidative stress and cellular apoptosis via activation of JAK2/STAT3 signaling.
    Int J Cardiol. 2024;395:131426.
    PubMed     Abstract available


  74. GOLINO M, Morello M, Marazzato J, Blasi F, et al
    Sex-related differences in non-ischemic myocardial injury in the emergency department: A real-world perspective.
    Int J Cardiol. 2024;395:131394.
    PubMed     Abstract available


  75. SAKAI A, Nagao M, Yamamoto A, Nakao R, et al
    (13)N-ammonia positron emission tomography for diagnosis and monitoring of ischemia without obstructive coronary artery disease.
    Int J Cardiol. 2024;395:131392.
    PubMed     Abstract available


  76. TIMOTEO AT, Branco LM, Galrinho A, Rio P, et al
    Global left ventricular myocardial work index and medium-term adverse cardiovascular events after ST-elevation myocardial infarction.
    Int J Cardiol. 2024 Jan 12:131781. doi: 10.1016/j.ijcard.2024.131781.
    PubMed     Abstract available


  77. ZHENG L, Zhu Y, Ma Y, Zhang H, et al
    Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jan 11:131779. doi: 10.1016/j.ijcard.2024.131779.
    PubMed     Abstract available


  78. DREGOESC MI, Tigu AB, Bekkering S, van der Heijden CDCC, et al
    Intermediate monocytes are associated with the first major adverse cardiovascular event in patients with stable coronary artery disease.
    Int J Cardiol. 2024 Jan 11:131780. doi: 10.1016/j.ijcard.2024.131780.
    PubMed     Abstract available


  79. DUSE DA, Kelm M, Erkens R
    Lactate load in acute myocardial infarction: Old but gold?
    Int J Cardiol. 2024 Jan 9:131771. doi: 10.1016/j.ijcard.2024.131771.
    PubMed    


  80. BERNHARD B, Heydari B, Abdullah S, Francis SA, et al
    Effect of six month's treatment with omega-3 acid ethyl esters on long-term outcomes after acute myocardial infarction: The OMEGA-REMODEL randomized clinical trial.
    Int J Cardiol. 2024 Jan 4:131698. doi: 10.1016/j.ijcard.2023.131698.
    PubMed     Abstract available


  81. FABRIS E, Boldrin C, Gregorio C, Pezzato A, et al
    The Prognostic impact of treatments evolution in STEMI.
    Int J Cardiol. 2024;394:131352.
    PubMed     Abstract available


  82. FEZZI S, Pighi M, Del Sole PA, Scarsini R, et al
    Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques.
    Int J Cardiol. 2024;394:131341.
    PubMed     Abstract available


    December 2023
  83. WU Y, Huang N, Sun T, Zhang B, et al
    Association between normalized lactate load and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Dec 23:131658. doi: 10.1016/j.ijcard.2023.131658.
    PubMed     Abstract available


  84. LAMBRAKIS K, Khan E, van den Merkhof A, Papendick C, et al
    Impacts of high sensitivity troponin T reporting on care and outcomes in clinical practice: Interactions between low troponin concentrations and participant sex within two randomized clinical trials.
    Int J Cardiol. 2023;393:131396.
    PubMed     Abstract available


  85. LIM J, King J, Williams T, Boyle A, et al
    Unchanged cellular inflammatory response following recurrent ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Dec 15:131656. doi: 10.1016/j.ijcard.2023.131656.
    PubMed     Abstract available


  86. MIRNA M
    Reply to: "The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?".
    Int J Cardiol. 2023 Dec 10:131646. doi: 10.1016/j.ijcard.2023.131646.
    PubMed    


  87. ELIA E, Bruno F, Crimi G, Wanha W, et al
    Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
    Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
    PubMed     Abstract available


  88. PELLICCIA F, Romiti S, Spunticchia F, Minati A, et al
    Educational tools may turn into decision-making strategies in clinical practice - The case of primary percutaneous coronary intervention risk scores.
    Int J Cardiol. 2023;392:131282.
    PubMed    


    November 2023
  89. YARLIOGLUES M, Karacali K, Ilhan BC, Oner DY, et al
    A retrospective study: Associationof C-reactive protein and uric acid to albumin ratio with the no-reflow phenomenonin patients with ST elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 28:131621. doi: 10.1016/j.ijcard.2023.131621.
    PubMed     Abstract available


  90. MORONI F, Corna G, Del Buono MG, Golino M, et al
    Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
    PubMed     Abstract available


  91. PENG N, Guo L, Wei Z, Wang X, et al
    Platelet mitochondrial DNA methylation: A novel biomarker for myocardial infarction - A preliminary study.
    Int J Cardiol. 2023 Nov 21:131606. doi: 10.1016/j.ijcard.2023.131606.
    PubMed     Abstract available


  92. LIVORI AC, Ademi Z, Ilomaki J, Pol D, et al
    No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia.
    Int J Cardiol. 2023 Nov 16:131593. doi: 10.1016/j.ijcard.2023.131593.
    PubMed     Abstract available


  93. BIANCHINI E, Lombardi M, Buonpane A, Ricchiuto A, et al
    Impact of thrombus aspiration on left ventricular remodeling and function in patients with ST-segment elevation myocardial infarction: A meta-analysis of randomized controlled trials.
    Int J Cardiol. 2023 Nov 16:131590. doi: 10.1016/j.ijcard.2023.131590.
    PubMed     Abstract available


  94. LI ZH, Zhong WF, Qiu CS, Yang P, et al
    Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
    PubMed     Abstract available


  95. LINDOW T, Mokhtari A, Nystrom A, Koul S, et al
    Comparison of diagnostic accuracy of current left bundle branch block and ventricular pacing ECG criteria for detection of occlusion myocardial infarction.
    Int J Cardiol. 2023 Nov 4:131569. doi: 10.1016/j.ijcard.2023.131569.
    PubMed     Abstract available


  96. DAI C, Yang Z, Liu M, Zhou Y, et al
    Prognostic value and clinical usefulness of PIANO score in patients undergoing primary percutaneous coronary intervention.
    Int J Cardiol. 2023;390:131258.
    PubMed     Abstract available


  97. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Impact of calcium on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention.
    Int J Cardiol. 2023;390:131254.
    PubMed     Abstract available


  98. NISHIJIMA S, Nagao M, Yamamoto A, Ichihara Y, et al
    Coronary artery bypass grafting transiently improves myocardial flow reserve in patients with impaired left ventricular function.
    Int J Cardiol. 2023;390:131231.
    PubMed     Abstract available


  99. ZHU Y, Wang Y, Liu X, Wang Y, et al
    Genetically predicted osteoprotegerin levels and the risk of cardiovascular diseases: A Mendelian randomization study.
    Int J Cardiol. 2023;390:131233.
    PubMed     Abstract available


  100. MASIERO G, Tarantini G
    Sex and cardiogenic shock: Still no time for answers but for evidences.
    Int J Cardiol. 2023;390:131224.
    PubMed    


  101. LUO X, Liu M, Wang S, Chen Y, et al
    Combining metabolomics and OCT to reveal plasma metabolic profiling and biomarkers of plaque erosion and plaque rupture in STEMI patients.
    Int J Cardiol. 2023;390:131223.
    PubMed     Abstract available


    October 2023
  102. BREEN TJ, Raphael CE, Ingraham B, Lane C, et al
    Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Int J Cardiol. 2023 Oct 30:131565. doi: 10.1016/j.ijcard.2023.131565.
    PubMed     Abstract available


  103. BICCIRE FG, Lip GYH, Pastori D
    Reply to: The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
    Int J Cardiol. 2023 Oct 21:131547. doi: 10.1016/j.ijcard.2023.131547.
    PubMed    


  104. LI Y, Yao S, Chen X
    The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?
    Int J Cardiol. 2023 Oct 20:131544. doi: 10.1016/j.ijcard.2023.131544.
    PubMed    


  105. CLAUDIA STOLLBERGER MD, Finsterer J
    More data on the association of Takotsubo syndrome and stroke are warranted.
    Int J Cardiol. 2023 Oct 20:131548. doi: 10.1016/j.ijcard.2023.131548.
    PubMed    


  106. AVANZAS P, de la Torre JM
    Seeking precision in percutaneous coronary revascularization: The best stent for each setting.
    Int J Cardiol. 2023;389:131222.
    PubMed    


  107. DE MICHIELI L, De Gaspari M, Sinigiani G, Lupi A, et al
    Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance.
    Int J Cardiol. 2023;389:131204.
    PubMed     Abstract available


  108. ZHANG S, Yang L, Guo S, Hu F, et al
    Mannose binding lectin-associated serine protease-1 is a novel contributor to myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2023;389:131193.
    PubMed     Abstract available


  109. CORTES C, Fernandez-Corredoira PM, Liu L, Lopez-Palop R, et al
    Long-term prognostic value of quantitative-flow-ratio-concordant revascularization in stable coronary artery disease.
    Int J Cardiol. 2023;389:131176.
    PubMed     Abstract available


  110. LYONS KS, Herity N, Lee G, Talbot C, et al
    Assay interference as a cause of false positive troponin T elevation in emergency department patients.
    Int J Cardiol. 2023;389:131165.
    PubMed     Abstract available


  111. JAIN SS, Yu J, Arnott C, Neal B, et al
    Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
    Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
    PubMed     Abstract available


  112. WANG C, Zhang M, Yan J, Wang R, et al
    Erratum to "Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction" [International Journal of Cardiology 372C (2023) 6-14].
    Int J Cardiol. 2023 Oct 10:131338. doi: 10.1016/j.ijcard.2023.131338.
    PubMed    


  113. WURDINGER M, Schweiger V, Gilhofer T, Cammann VL, et al
    Twenty-five-year trends in incidence, angiographic appearance, and management of spontaneous coronary artery dissection.
    Int J Cardiol. 2023 Oct 10:131429. doi: 10.1016/j.ijcard.2023.131429.
    PubMed     Abstract available


  114. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
    Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
    Int J Cardiol. 2023;388:131167.
    PubMed     Abstract available


  115. AHN JH, Kim MC, Ahn Y, Cho DI, et al
    Culprit lesion plaque characteristics and angiopoietin like 4 in acute coronary syndrome: A virtual histology-intravascular ultrasound analysis.
    Int J Cardiol. 2023;388:131164.
    PubMed     Abstract available


  116. CORNELISSEN A, Florescu RA, Reese S, Behr M, et al
    In-vivo assessment of vascular injury for the prediction of in-stent restenosis.
    Int J Cardiol. 2023;388:131151.
    PubMed     Abstract available


  117. LECHNER I, Reindl M, Metzler B, Reinstadler SJ, et al
    Embracing nomograms: A leap in the dark for enhanced risk stratification in STEMI.
    Int J Cardiol. 2023;388:131106.
    PubMed    


    September 2023
  118. EMMERT-FEES KMF, Luhar S, O'Flaherty M, Kypridemos C, et al
    Forecasting the mortality burden of coronary heart disease and stroke in Germany: National trends and regional inequalities.
    Int J Cardiol. 2023 Sep 25:131359. doi: 10.1016/j.ijcard.2023.131359.
    PubMed     Abstract available


  119. YAMAMOTO T, Kawamori H, Toba T, Kakizaki S, et al
    Clinical impact of optical coherence tomography findings after drug-coated balloon treatment for patients with acute coronary syndromes.
    Int J Cardiol. 2023;387:131149.
    PubMed     Abstract available


  120. CHONG TK, Chen J, Lyu L, Wei Y, et al
    Clinical characteristics and outcome correlates of Chinese patients with takotsubo syndrome: Results from the first Chinese takotsubo syndrome registry.
    Int J Cardiol. 2023;387:131129.
    PubMed     Abstract available


  121. MITSUTAKE Y, Ishii J, Fukumoto Y, Ito S, et al
    Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease.
    Int J Cardiol. 2023;387:131138.
    PubMed     Abstract available


  122. ROZADO J, Avanzas P
    Complete revascularization in STEMI and multivessel coronary artery disease: In search of the best strategy.
    Int J Cardiol. 2023;387:131124.
    PubMed    


  123. WU H, Xiao Z
    A knowledge graph-based analytical model for mining clinical value of drug stress echocardiography for diagnosis, risk stratification and prognostic evaluation of coronary artery disease.
    Int J Cardiol. 2023;387:131107.
    PubMed     Abstract available


  124. SHARIFOV OF, Denney TS Jr, Girard AA, Gupta H, et al
    Coronary artery disease is associated with impaired atrial function regardless of left ventricular filling pressure.
    Int J Cardiol. 2023;387:131102.
    PubMed     Abstract available


  125. XU C, Meng J, He J
    History of peripheral artery disease as a cardiovascular risk predictor of patients with acute coronary syndrome.
    Int J Cardiol. 2023;387:131105.
    PubMed    


  126. LUCCI C, Cosentino N, Marenzi G
    Unstable angina: A clinical entity on the verge of extinction?
    Int J Cardiol. 2023 Sep 5:131329. doi: 10.1016/j.ijcard.2023.131329.
    PubMed    


  127. FUJII T, Kasai S, Kawamura Y, Yoshimachi F, et al
    Temporal variations in ischemic and bleeding event risks after acute coronary syndrome during dual antiplatelet therapy.
    Int J Cardiol. 2023 Sep 5:131340. doi: 10.1016/j.ijcard.2023.131340.
    PubMed     Abstract available


  128. VOGEL B, Tycinska A, Sambola A
    Cardiogenic shock in women - A review and call to action.
    Int J Cardiol. 2023;386:98-103.
    PubMed    


  129. WANG H, Tucker WJ, Jonnagaddala J, Schutte AE, et al
    Using machine learning to predict cardiovascular risk using self-reported questionnaires: Findings from the 45 and Up Study.
    Int J Cardiol. 2023;386:149-156.
    PubMed     Abstract available


  130. LIEDER HR, Adam V, Skyschally A, Sturek M, et al
    Attenuation of ST-segment elevation by ischemic preconditioning: Reflection of cardioprotection in Gottingen but not in Ossabaw minipigs.
    Int J Cardiol. 2023;386:109-117.
    PubMed     Abstract available


  131. ANGIOLILLO DJ, Erlinge D, Ferreiro JL, Gale CP, et al
    European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey.
    Int J Cardiol. 2023;386:8-16.
    PubMed     Abstract available


  132. CANDREVA A, Lodi Rizzini M, Schweiger V, Gallo D, et al
    Is spontaneous coronary artery dissection (SCAD) related to local anatomy and hemodynamics? An exploratory study.
    Int J Cardiol. 2023;386:1-7.
    PubMed     Abstract available


  133. TANG LH, Doherty P, Skou ST, Harrison A, et al
    Optimal outcomes from cardiac rehabilitation are associated with longer-term follow-up and risk factor status at 12 months: An observational registry-based study.
    Int J Cardiol. 2023;386:134-140.
    PubMed     Abstract available


  134. OOMENS T, Vos NS, van der Schaaf RJ, Amoroso G, et al
    EXpansion of stents after intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries.
    Int J Cardiol. 2023;386:24-29.
    PubMed     Abstract available


    August 2023
  135. BICCIRE FG, Lip GYH, Pastori D
    Reply to: Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
    Int J Cardiol. 2023 Aug 31:131305. doi: 10.1016/j.ijcard.2023.131305.
    PubMed    


  136. TROMBARA F, Cosentino N, Marenzi G
    Intracranial haemorrhage in acute myocardial infarction: A rare but dramatic complication.
    Int J Cardiol. 2023 Aug 30:131300. doi: 10.1016/j.ijcard.2023.131300.
    PubMed    


  137. LI F, Peng J, Lu Y, Zhou M, et al
    Blockade of CXCR4 promotes macrophage autophagy through the PI3K/AKT/mTOR pathway to alleviate coronary heart disease.
    Int J Cardiol. 2023 Aug 29:131303. doi: 10.1016/j.ijcard.2023.131303.
    PubMed     Abstract available


  138. WAN P, Xu W, Jiang Q
    The C2HEST and mC2HEST scores to predict the risk of new onset atrial fibrillation after presentation with acute coronary syndrome.
    Int J Cardiol. 2023 Aug 25:131280. doi: 10.1016/j.ijcard.2023.131280.
    PubMed    


  139. EFTEKHARI A, van de Hoef TP, Hoshino M, Lee JM, et al
    Changes in microvascular resistance following percutaneous coronary intervention - From the ILIAS global registry.
    Int J Cardiol. 2023 Aug 25:131296. doi: 10.1016/j.ijcard.2023.131296.
    PubMed     Abstract available


  140. KUMAR R, Shaikh AH, Kumar A, Solangi BA, et al
    Age and gender-based categorization of very premature, premature, and non-premature acute myocardial infarction: A comparison of clinical and angiographic profile and in-hospital outcomes.
    Int J Cardiol. 2023 Aug 23:131292. doi: 10.1016/j.ijcard.2023.131292.
    PubMed     Abstract available


  141. JESSEN N, Andersen JA, Tayal B, Ostergaard L, et al
    Takotsubo syndrome and stroke risk: A nationwide register-based study.
    Int J Cardiol. 2023 Aug 22:131283. doi: 10.1016/j.ijcard.2023.131283.
    PubMed     Abstract available


  142. CHOI BG, Park JY, Rha SW, Noh YK, et al
    Pre-test probability for coronary artery disease in patients with chest pain based on machine learning techniques.
    Int J Cardiol. 2023;385:85-93.
    PubMed     Abstract available


  143. GURGOGLIONE FL, Rizzello D, Giacalone R, Ferretti M, et al
    Precipitating factors in patients with spontaneous coronary artery dissection: Clinical, laboratoristic and prognostic implications.
    Int J Cardiol. 2023;385:1-7.
    PubMed     Abstract available


  144. DAVIES A, Wenzl FA, Li XS, Winzap P, et al
    Short and medium chain acylcarnitines as markers of outcome in diabetic and non-diabetic subjects with acute coronary syndromes.
    Int J Cardiol. 2023 Aug 11:131261. doi: 10.1016/j.ijcard.2023.131261.
    PubMed     Abstract available


  145. YAN T, Li X, Wang X, Zhang Y, et al
    Rhodiola wallichiana var.cholaensis protects against myocardial ischemia-reperfusion injury by attenuating oxidative stress-mediated apoptosis via enhancing Nrf2 signaling.
    Int J Cardiol. 2023;384:62-73.
    PubMed     Abstract available


  146. IANNACCONE M, Bertaina M, Morici N, Chieffo A, et al
    Impact of sex in cardiogenic shock outcomes: Still not seeing it coming?
    Int J Cardiol. 2023;384:50-51.
    PubMed    


  147. PAVSIC N, Zbacnik R, Berden P, Kacar P, et al
    The association between myocardial ischemia and myocardial dysfunction in adult patients with systemic right ventricle - A single centre multimodality study.
    Int J Cardiol. 2023;384:31-36.
    PubMed     Abstract available


  148. JIANG Y, Zhao Y, Li ZY, Chen S, et al
    Potential roles of microRNAs and long noncoding RNAs as diagnostic, prognostic and therapeutic biomarkers in coronary artery disease.
    Int J Cardiol. 2023;384:90-99.
    PubMed     Abstract available


    July 2023
  149. DAKSHI A, Salmon T, Collinson P, Ihsan J, et al
    Unstable angina in the context of high-sensitive troponins: Still a marker of high risk? A comparison of outcomes with adjudicated type 1 myocardial infarction.
    Int J Cardiol. 2023 Jul 29:131226. doi: 10.1016/j.ijcard.2023.131226.
    PubMed     Abstract available


  150. DE KONING MLY, Al Ali L, Bourgonje AR, Assa S, et al
    Associations of systemic oxidative stress with functional outcomes after ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jul 28:131214. doi: 10.1016/j.ijcard.2023.131214.
    PubMed     Abstract available


  151. XIAO X
    Prediction scores for new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Two sides of the same coin.
    Int J Cardiol. 2023 Jul 28:131221. doi: 10.1016/j.ijcard.2023.131221.
    PubMed    


  152. ZHANG P, Pang S, Du L, Li J, et al
    Clinical characteristics and outcomes of patients with intracerebral hemorrhage after acute myocardial infarction.
    Int J Cardiol. 2023 Jul 25:131218. doi: 10.1016/j.ijcard.2023.131218.
    PubMed     Abstract available


  153. ASSAF A, van der Graaf M, van Boven N, van Ettinger MJB, et al
    Effect of myocardial scar size on the risk of ventricular arrhythmias in patients with chronic Total coronary occlusion.
    Int J Cardiol. 2023 Jul 21:131205. doi: 10.1016/j.ijcard.2023.131205.
    PubMed     Abstract available


  154. JONG CB, Lu TS, Chen TY, Chen CK, et al
    Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
    Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
    PubMed     Abstract available


  155. DE ANGELIS E, Bochaton T, Ammirati E, Tedeschi A, et al
    Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes.
    Int J Cardiol. 2023;383:82-88.
    PubMed     Abstract available


  156. ANAND VV, Zhe ELC, Chin YH, Goh RSJ, et al
    Socioeconomic deprivation and prognostic outcomes in acute coronary syndrome: A meta-analysis using multidimensional socioeconomic status indices.
    Int J Cardiol. 2023;383:140-150.
    PubMed     Abstract available


  157. POMPEI G, Campo G, Ruggiero R, Maffeo D, et al
    Long-term outcomes of patients treated with sirolimus-eluting resorbable magnesium scaffolds: Insights from the SHERPA-MAGIC study.
    Int J Cardiol. 2023;383:1-7.
    PubMed     Abstract available


  158. LOPEZ-PALOP R, Carrillo P, Leithold G, Lozano I, et al
    Accuracy of the angiography-based quantitative flow ratio in intermediate left main coronary artery lesions and comparison with visual estimation.
    Int J Cardiol. 2023;383:8-14.
    PubMed     Abstract available


  159. SPIRITO A, Valgimigli M, Cao D, Baber U, et al
    Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT.
    Int J Cardiol. 2023;383:24-32.
    PubMed     Abstract available


  160. CASTALDI G, Bharadwaj AS, Bagur R, Van Spall HGC, et al
    Prevalence and outcomes of type 2 myocardial infarction in patients with cancer: A retrospective analysis from the National Inpatient Sample dataset.
    Int J Cardiol. 2023 Jul 11:131154. doi: 10.1016/j.ijcard.2023.131154.
    PubMed     Abstract available


  161. SAITO T, Fujisaki T, Aikawa T, Kampaktsis PN, et al
    Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: A systematic review and network meta-analysis.
    Int J Cardiol. 2023 Jul 9:131157. doi: 10.1016/j.ijcard.2023.131157.
    PubMed     Abstract available


  162. MIRNA M, Berezin A, Schmutzler L, Demirel O, et al
    Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction - a meta-analysis.
    Int J Cardiol. 2023 Jul 7:131160. doi: 10.1016/j.ijcard.2023.131160.
    PubMed     Abstract available


  163. LIAO J, Zhang M, Xu R, Wu R, et al
    Soluble interleukin-2 receptor predicts acute kidney injury and in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2023 Jul 7:131156. doi: 10.1016/j.ijcard.2023.131156.
    PubMed     Abstract available


  164. MILLET LM, Ali MJ, Mohandas R
    Practice patterns and clinical outcomes of severe coronary artery disease in dialysis patients.
    Int J Cardiol. 2023;382:1-2.
    PubMed    


    June 2023
  165. CARVALHO A, Ji Z, Zhang R, Zuo W, et al
    Inhibition of miR-195-3p protects against cardiac dysfunction and fibrosis after myocardial infarction.
    Int J Cardiol. 2023 Jun 23:131128. doi: 10.1016/j.ijcard.2023.131128.
    PubMed     Abstract available


  166. SCHMITT A, Schupp T, Rusnak J, Ruka M, et al
    Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?
    Int J Cardiol. 2023;381:105-111.
    PubMed     Abstract available


  167. FUJII T
    Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk".
    Int J Cardiol. 2023;381:1.
    PubMed    


  168. ZHANG L, Li Y, Li H, Wang R, et al
    Association between admission heart rate and major adverse cardiovascular events in acute myocardial infarction participants with different left ventricular ejection fraction.
    Int J Cardiol. 2023 Jun 15:131122. doi: 10.1016/j.ijcard.2023.131122.
    PubMed     Abstract available


  169. PARCO C, Trostler J, Brockmeyer M, Hoss A, et al
    Risk-adjusted management in catheterization procedures for non-ST-segment elevation myocardial infarction: A standard operating procedure pilot study.
    Int J Cardiol. 2023 Jun 9:S0167-5273(23)00836.
    PubMed     Abstract available


  170. MAKUVIRE TT, Latif Z, Kumar P, Samad Z, et al
    Trends in ischemic heart disease among females in low-and middle-income countries from 1990 to 2019.
    Int J Cardiol. 2023 Jun 7:S0167-5273(23)00838.
    PubMed     Abstract available


  171. ROMAGNOLI E, Burzotta F, Cerracchio E, Russo G, et al
    Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Int J Cardiol. 2023 Jun 6:S0167-5273(23)00742.
    PubMed     Abstract available


  172. GUREVITZ C, Assali A, Mohsan J, Gmach SF, et al
    The obesity paradox in patients with acute coronary syndromes over 2 decades - the ACSIS registry 2000-2018.
    Int J Cardiol. 2023;380:48-55.
    PubMed     Abstract available


  173. LOPEZ-PALOP R, Carrillo P, Lozano I
    Non-hyperemic, non pressure wire, coronary physiology. A further step towards the generalization of physiology in the cath-lab?
    Int J Cardiol. 2023;380:1-3.
    PubMed    


    May 2023
  174. BICCIRE FG, Tanzilli G, Prati F, Sammartini E, et al
    Prediction of new onset atrial fibrillation in patients with acute coronary syndrome undergoing percutaneous coronary intervention using the C2HEST and mC2HEST scores: A report from the multicenter REALE-ACS registry.
    Int J Cardiol. 2023 May 16:S0167-5273(23)00715.
    PubMed     Abstract available


  175. KLUGER N
    A case of misdiagnosed vasospastic angina in the last of us?
    Int J Cardiol. 2023;379:15.
    PubMed    


  176. CROOIJMANS C, Jansen TPJ, Konst RE, Woudstra J, et al
    Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
    Int J Cardiol. 2023;379:1-8.
    PubMed     Abstract available


  177. ZHAO CX, Wei L, Dong JX, He J, et al
    Nomograms referenced by cardiac magnetic resonance in the prediction of cardiac injuries in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 May 13:S0167-5273(23)00700.
    PubMed     Abstract available


  178. ZUIN M, di Fusco SA, De Caterina R, Roncon L, et al
    Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00649.
    PubMed     Abstract available


  179. XIN A, Li K, Qian G, Chen Y, et al
    Reply to Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 May 5:S0167-5273(23)00653.
    PubMed    


  180. LEE WJ, Cheng H, Whitney BM, Nance RM, et al
    Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00648.
    PubMed     Abstract available


  181. AHMED AI, Al-Mallah MH
    Reply to SPECT and STE: Which one is better in incremental prognostic value over CCTA.
    Int J Cardiol. 2023;378:164-165.
    PubMed    


  182. GAUTHIER V, Lafrance M, Barthoulot M, Rousselet L, et al
    Long-term follow-up of survivors of a first acute coronary syndrome: Results from the French MONICA registries from 2009 to 2017.
    Int J Cardiol. 2023;378:138-143.
    PubMed     Abstract available


  183. LANDI A
    Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk.
    Int J Cardiol. 2023;378:10.
    PubMed    


  184. KIMURA S
    Reliability of immature neutrophils in the risk stratification of acute coronary syndrome lesions.
    Int J Cardiol. 2023;378:111-112.
    PubMed    


  185. HERMANN R, Mestre Cordero VE, Fernandez Pazos MLM, Reznik FJ, et al
    Role of autophagy in simulated ischemic-reperfused left atrial myocardium.
    Int J Cardiol. 2023;378:77-88.
    PubMed     Abstract available


  186. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    PubMed     Abstract available


  187. WANG Z, Yang J, Li C, Huang J, et al
    Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Int J Cardiol. 2023;378:11-19.
    PubMed     Abstract available


  188. VAN DE HOEF TP, Boerhout CKM, Piek JJ
    Reply to: "Do we still need to perform FFR and PCI".
    Int J Cardiol. 2023;378:22.
    PubMed    


  189. GRAGNANO F, Montalto C, Oreglia JA, Calabro P, et al
    Physiology-guided revascularization of non-culprit lesions in patients with STEMI: Could vFFR be the way?
    Int J Cardiol. 2023;378:20-21.
    PubMed    


  190. VARMA Y, Jena NK, Arsene C, Patel K, et al
    Disparities in the management of non-ST-segment elevation myocardial infarction in the United States.
    Int J Cardiol. 2023 May 1:S0167-5273(23)00592.
    PubMed     Abstract available


    April 2023
  191. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
    Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
    Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
    PubMed     Abstract available


  192. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    PubMed     Abstract available


  193. FLYGARE O, Boberg J, Ruck C, Hofmann R, et al
    Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study.
    Int J Cardiol. 2023 Apr 18:S0167-5273(23)00576.
    PubMed     Abstract available


  194. MORI R, Macaya F, Giacobbe F, Salinas P, et al
    Clinical and angiographic features of SCAD type 4.
    Int J Cardiol. 2023;377:22-25.
    PubMed     Abstract available


  195. LAKE P, Halbach M, Kardasch M, Mauri V, et al
    Comparison of vessel fractional flow reserve with invasive resting full-cycle ratio in patients with intermediate coronary lesions.
    Int J Cardiol. 2023;377:1-8.
    PubMed     Abstract available


  196. REN L, Han Y, Long M, Yan L, et al
    Association with carotid plaque parameters detected on contrast-enhanced ultrasound and coronary artery plaque progression in non-culprit lesions: A retrospective study.
    Int J Cardiol. 2023;377:115-122.
    PubMed     Abstract available


  197. VAN DE HOEF TP, Stegehuis VE, Madera-Cambero MI, van Royen N, et al
    Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-study.
    Int J Cardiol. 2023;377:9-16.
    PubMed     Abstract available


  198. ISHII H
    Cardio-renal interaction in coronary artery disease.
    Int J Cardiol. 2023;377:17-18.
    PubMed    


  199. ISHII M, Nakamura T, Tsujita K
    Impact of veno-arterial extracorporeal membrane oxygenation on mortality in cardiogenic shock after acute myocardial infarction: Real-world evidence.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00521.
    PubMed    


  200. NAGATA T, Minami Y, Katsura A, Asakura K, et al
    Optical coherence tomography factors for adverse events in patients with severe coronary calcification.
    Int J Cardiol. 2023;376:28-34.
    PubMed     Abstract available


  201. OSAWA K
    Can carotid plaque assessment perform the role of a risk predictor for secondary prevention?
    Int J Cardiol. 2023;376:154-155.
    PubMed    


  202. ZHANG ZH
    Thrombospondin-1, a potential target in acute coronary syndrome.
    Int J Cardiol. 2023;376:27.
    PubMed    


  203. CARBONE RG, Puppo F
    Breast arterial calcification and epicardial adipose tissue volume: Emerging risk factors of cardiovascular diseases.
    Int J Cardiol. 2023;376:134.
    PubMed    


  204. CARBONE RG, Puppo F
    The role of adrenomedullin in acute coronary syndrome.
    Int J Cardiol. 2023;376:22-23.
    PubMed    


  205. TSIREBOLOS G, Tsoporis JN, Drosatos IA, Izhar S, et al
    Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Int J Cardiol. 2023;376:127-133.
    PubMed     Abstract available


  206. TSAI TY, Onuma Y, Serruys PW
    Do we still need to perform FFR and PCI?
    Int J Cardiol. 2023;376:48.
    PubMed    


  207. MARTIJN S, Maarten F, Danielle Z, Toshiki K, et al
    Psychosocial predictors for cardiac rehabilitation participation for patients with coronary artery disease.
    Int J Cardiol. 2023;376:18-21.
    PubMed     Abstract available


  208. JAMMOUL N, Mercier G, Roubille F
    Could colchicine reduce cardiovascular events in coronary artery disease without increasing all-cause mortality: Avoid optical illusions!
    Int J Cardiol. 2023;376:125-126.
    PubMed    


    March 2023
  209. DENEGRI A, Magnani G, Kraler S, Bruno F, et al
    History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00454.
    PubMed     Abstract available


  210. POZZI M, Payet C, Polazzi S, L'Hospital A, et al
    Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock after acute myocardial infarction: Insights from a French nationwide database.
    Int J Cardiol. 2023 Mar 20:S0167-5273(23)00446.
    PubMed     Abstract available


  211. MA Z, Wang M, Xu X, Zhang Y, et al
    Thrombospondin-1 plasma levels associated with in-hospital major adverse cardiovascular events in patients with acute coronary syndrome.
    Int J Cardiol. 2023;375:98-103.
    PubMed     Abstract available


  212. BELLINO M, Piscione F
    Spontaneous coronary artery dissection: do we need different tailored strategies?
    Int J Cardiol. 2023;375:7-8.
    PubMed    


  213. SIMSEK B, Tajti P, Carlino M, Ojeda S, et al
    External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries.
    Int J Cardiol. 2023;375:14-20.
    PubMed     Abstract available


  214. WANG IC, Lin JH, Lee WS, Liu CH, et al
    Baicalein and luteolin inhibit ischemia/reperfusion-induced ferroptosis in rat cardiomyocytes.
    Int J Cardiol. 2023;375:74-86.
    PubMed     Abstract available


  215. LOPEZ-PALOP R, Lozano I, Carrillo P
    COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages?
    Int J Cardiol. 2023;375:144-146.
    PubMed    


  216. BENATTI G, Gragnano F, Vignali L, Calabro P, et al
    Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00393.
    PubMed     Abstract available


  217. SABOUR S
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00365.
    PubMed    


  218. KOOLAJI S, Tehrani YS, Azadnajafabad S, Moghaddam SS, et al
    A 30-year trend of ischemic heart disease burden in a developing country; a systematic analysis of the global burden of disease study 2019 in Iran.
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00339.
    PubMed     Abstract available


  219. TANAKA S, Okada K, Kitahara H, Luikart H, et al
    Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation.
    Int J Cardiol. 2023 Mar 7:S0167-5273(23)00343.
    PubMed     Abstract available


  220. DAYEM KA, Younis O, Zarif B, Attia S, et al
    Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00329.
    PubMed     Abstract available


  221. PELLICCIA F, Camici PG
    Updates on MINOCA and INOCA through the 2022 publications in the International Journal of Cardiology.
    Int J Cardiol. 2023;374:8-11.
    PubMed    


  222. WAN M, Lu Y, Mao B, Yu S, et al
    Immature neutrophil is associated with coronary plaque vulnerability based on optical coherence tomography analysis.
    Int J Cardiol. 2023;374:89-93.
    PubMed     Abstract available


  223. SCHINDLER TH, Bhandiwad AR, Jain S
    Role of cardiac magnetic resonance imaging in the prediction of left ventricular remodeling after infarction: Emerging new concepts?
    Int J Cardiol. 2023;374:127-128.
    PubMed    


  224. CILIBERTI G, Verdoia M, Musella F, Ceriello L, et al
    MINOCA in Men and Women: Different Conditions and a Single Destiny?
    Int J Cardiol. 2023;374:6-7.
    PubMed    


  225. ROSSELLO X, Blaya-Pena L, Siquier-Padilla J
    The COMBO stent: Real-world patients vs. objective performance criteria.
    Int J Cardiol. 2023;374:33-34.
    PubMed    


  226. MAHMOUD HT, Berton G, Cordiano R, Palmieri R, et al
    Microalbuminuria during acute coronary syndrome: Association with 22-year mortality and causes of death. The ABC-8* study on heart disease. (*ABC is an acronym for Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2023;374:100-107.
    PubMed     Abstract available


  227. XU J, Fan Y, Zhou R, Shao J, et al
    The interaction of persistent antiphospholipid antibodies positivity and cigarette smoking is associated with an increased risk of cardiovascular events: Cross-sectional and longitudinal analysis.
    Int J Cardiol. 2023;374:108-114.
    PubMed     Abstract available


  228. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
    Int J Cardiol. 2023;374:27-32.
    PubMed     Abstract available


    February 2023
  229. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    PubMed     Abstract available


  230. DHINDSA DS, Desai SR, Jin Q, Sandesara PB, et al
    Circulating progenitor cells and outcomes in patients with coronary artery disease.
    Int J Cardiol. 2023;373:7-16.
    PubMed     Abstract available


  231. WEINTRAUB WS, Mancini GBJ, Boden WE
    Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Int J Cardiol. 2023;373:39-43.
    PubMed     Abstract available


  232. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    PubMed     Abstract available


  233. WAKABAYASHI K, Higuchi S, Miyachi H, Minatsuki S, et al
    Clinical features and predictors of non-cardiac death in patients hospitalised for acute myocardial infarction: Insights from the Tokyo CCU network multicentre registry.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00238.
    PubMed     Abstract available


  234. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    PubMed     Abstract available


  235. LIM J, Davies A, Brienesse S, Mabotuwana NS, et al
    Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00123.
    PubMed     Abstract available


  236. CAMERON JD
    Non-hyperemic pressure-derived indices for guiding coronary intervention: Assessing comparative use and application.
    Int J Cardiol. 2023;372:46-47.
    PubMed    


  237. WILLIAMS MGL, Dastidar A, Liang K, Johnson TW, et al
    Sex differences in patients with acute coronary syndromes and non-obstructive coronary arteries: Presentation and outcome.
    Int J Cardiol. 2023;372:15-22.
    PubMed     Abstract available


    January 2023
  238. YOSHII T, Matsuzawa Y, Kato S, Sato R, et al
    Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00121.
    PubMed     Abstract available


  239. PINGITORE A
    Editorial on the manuscript "Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction".
    Int J Cardiol. 2023 Jan 19:S0167-5273(23)00059.
    PubMed    


  240. XING Y, Qiu Y, Yang L, Yuan Z, et al
    Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model.
    Int J Cardiol. 2023;371:420-426.
    PubMed     Abstract available


  241. WONG MYZ, Yap JJL, Chih HJ, Yan BPY, et al
    Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration.
    Int J Cardiol. 2023;371:84-91.
    PubMed     Abstract available


  242. NARANG N, Nakamura M, Imamura T
    Disparities in mechanical circulatory support utilization post cardiac arrest: An uncomfortable reality.
    Int J Cardiol. 2023;371:126-127.
    PubMed    


  243. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:80-81.
    PubMed    


  244. PICA S, Di Odoardo L, Testa L, Bollati M, et al
    Collateral presence and extent do not predict myocardial viability and ischemia in chronic total occlusions: A stress-CMR study.
    Int J Cardiol. 2023;371:10-15.
    PubMed     Abstract available


  245. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    PubMed     Abstract available


  246. FEENSTRA RGT, Seitz A, Boerhout CKM, de Winter RJ, et al
    Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index.
    Int J Cardiol. 2023;371:16-20.
    PubMed     Abstract available


  247. HAO T, Jiang Y, Wu C, Li C, et al
    Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China.
    Int J Cardiol. 2023;371:229-235.
    PubMed     Abstract available


  248. WANG L, Maehara A, Zhang X, Lv R, et al
    Quantification of patient-specific coronary material properties and their correlations with plaque morphological characteristics: An in vivo IVUS study.
    Int J Cardiol. 2023;371:21-27.
    PubMed     Abstract available


  249. GULATI M, Khan N, George M, Berry C, et al
    Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.
    Int J Cardiol. 2023;371:28-39.
    PubMed     Abstract available


  250. DU L, Wang P, Chen H, Zhang Y, et al
    Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:82.
    PubMed    


  251. DZIEWIERZ A
    The time is always right to do what is right: TAVI and timing of PCI.
    Int J Cardiol. 2023;371:128-129.
    PubMed    


  252. AHMED AI, Al Rifai M, Alahdab F, Saad JM, et al
    Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Int J Cardiol. 2023;371:465-471.
    PubMed     Abstract available


  253. GRAGNANO F, Pelliccia F, Cesaro A, Calabro P, et al
    Geographic variations in percutaneous versus surgical coronary revascularization: A global perspective from the SYNTAXES trial.
    Int J Cardiol. 2023;371:132-134.
    PubMed    


  254. SCALONE G, Di Vito L, Mariani L, Silenzi S, et al
    Which therapy for MINOCA patients? "Dazed and confused for so long, it is not true".
    Int J Cardiol. 2023;371:78-79.
    PubMed    


  255. GILANI A, Maknojia A, Mufty M, Patel S, et al
    Mechanical circulatory device utilization in cardiac arrest: Racial and gender disparities and impact on mortality.
    Int J Cardiol. 2023;371:460-464.
    PubMed     Abstract available


  256. AW A, de Jong MC, Varghese S, Lee J, et al
    A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy.
    Int J Cardiol. 2023;371:287-292.
    PubMed     Abstract available


  257. FUJII T, Endo S, Tsuchiya R, Nagamatsu H, et al
    Estimation of adverse events associated with P2Y12 receptor inhibitors stratified by academic research consortium for high bleeding risk criteria in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 14:S0167-5273(23)00061.
    PubMed     Abstract available


  258. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    PubMed     Abstract available


  259. LIARAKOS AL, Tran P, Keegan M, Robbins T, et al
    Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients with acute coronary syndrome (REGULATE-ACS).
    Int J Cardiol. 2023;370:26-34.
    PubMed     Abstract available


  260. BULLUCK H, Mozid AM
    Optimising patient selection for CTO PCI - The PICA approach.
    Int J Cardiol. 2023;370:445-446.
    PubMed    


  261. PROENCA T, Pinto RA, Carvalho MM, Rocha A, et al
    Sex disparities and dyslipidemic control in a coronary rehabilitation program.
    Int J Cardiol. 2023;370:72-74.
    PubMed     Abstract available


  262. LAENENS D, van der Bijl P, Stassen J, Rossi AC, et al
    Introduction to hemodynamic forces by echocardiography.
    Int J Cardiol. 2023;370:442-444.
    PubMed     Abstract available


  263. SALAMANCA J, Garcia-Guimaraes M, Sabate M, Sanz-Ruiz R, et al
    Multivessel spontaneous coronary artery dissection: Clinical features, angiographic findings, management, and outcomes.
    Int J Cardiol. 2023;370:65-71.
    PubMed     Abstract available


  264. KAMBIC T, Sarabon N, Hadzic V, Lainscak M, et al
    Physical activity and sedentary behaviour following combined aerobic and resistance training in coronary artery disease patients: A randomised controlled trial.
    Int J Cardiol. 2023;370:75-79.
    PubMed     Abstract available


  265. LECHNER I, Reindl M, Reinstadler SJ
    Acute coronary syndrome without standard modifiable cardiovascular risk factors (SMuRF): More questions than answers.
    Int J Cardiol. 2023;370:409-410.
    PubMed    


  266. RUSSO G, Pedicino D, Chiastra C, Vinci R, et al
    Coronary artery plaque rupture and erosion: Role of wall shear stress profiling and biological patterns in acute coronary syndromes.
    Int J Cardiol. 2023;370:356-365.
    PubMed     Abstract available


  267. D'ANCONA G, Massussi M, Savardi M, Signoroni A, et al
    Deep learning to detect significant coronary artery disease from plain chest radiographs AI4CAD.
    Int J Cardiol. 2023;370:435-441.
    PubMed     Abstract available


  268. SIMSEK B, Brilakis ES
    Reply to "Letter to the editor in response to the paper by Simsek et al. 2022".
    Int J Cardiol. 2023;370:177.
    PubMed    


  269. ABOUL-HASSAN SS, Stankowski T, Marczak J, Perek B, et al
    Long-term outcomes of patients receiving right internal thoracic artery or radial artery as a second arterial conduit. A propensity score matching study.
    Int J Cardiol. 2023;370:136-142.
    PubMed     Abstract available


  270. ARCHILLETTI F, Ricci F, Pelliccia F, Dangas G, et al
    Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Int J Cardiol. 2023;370:122-128.
    PubMed     Abstract available


  271. GRIGORIAN-SHAMAGIAN L, Oteo JF, Gutierrez-Barrios A, Abdul-Jawad Altisent O, et al
    Endothelial dysfunction in patients with angina and non-obstructed coronary arteries is associated with an increased risk of mayor cardiovascular events. Results of the Spanish ENDOCOR registry.
    Int J Cardiol. 2023;370:18-25.
    PubMed     Abstract available


  272. QIU M, Luo F, Du L
    SMuRF-less ACS patients have higher risk of mortality?
    Int J Cardiol. 2023;370:83.
    PubMed    


  273. SHOJI S, Kohsaka S, Kumamaru H, Nishimura S, et al
    Risk prediction models in patients undergoing percutaneous coronary intervention: A collaborative analysis from a Japanese administrative dataset and nationwide academic procedure registry.
    Int J Cardiol. 2023;370:90-97.
    PubMed     Abstract available


  274. NARDIN M, Pivato CA, Cao D, Sartori S, et al
    The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
    Int J Cardiol. 2023;370:149-155.
    PubMed     Abstract available


  275. ABTAN J, Bhatt DL, Elbez Y, Ducrocq G, et al
    External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued
    Int J Cardiol. 2023;370:51-57.
    PubMed     Abstract available


  276. DI SERAFINO L, Barbato E, Serino F, Svanerud J, et al
    Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis.
    Int J Cardiol. 2023;370:84-89.
    PubMed     Abstract available


  277. GALLI M, Benenati S, Zito A, Capodanno D, et al
    Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.
    Int J Cardiol. 2023;370:58-64.
    PubMed     Abstract available


  278. ARGIRO A, Zampieri M, Dei LL, Ferrantini C, et al
    Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Int J Cardiol. 2023;370:271-278.
    PubMed     Abstract available


    December 2022
  279. GALIMZHANOV A, Sabitov Y, Guclu E, Tenekecioglu E, et al
    Phenotyping for percutaneous coronary intervention and long-term recurrent weighted outcomes.
    Int J Cardiol. 2022 Dec 24:S0167-5273(22)01919.
    PubMed     Abstract available


  280. SU W, Song S, Dong H, Wu H, et al
    Identifying and comparing low-value care recommendations for coronary heart disease prevention, diagnosis, and treatment in the US and China.
    Int J Cardiol. 2022 Dec 22:S0167-5273(22)01915.
    PubMed     Abstract available


  281. XIN A, Li K, Yan LL, Chandramouli C, et al
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: A multi-center study.
    Int J Cardiol. 2022 Dec 21:S0167-5273(22)01918.
    PubMed     Abstract available


  282. ZUIN M, Rigatelli G, Battisti V, Costola G, et al
    Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01914.
    PubMed     Abstract available


  283. MORONI F, Azzalini L, Caixeta A, Oliveira TP, et al
    TIMI flow and myocardial blushing after rescue PCI and cardiac magnetic resonance: Results from the Myocardial Salvage After Rescue Angioplasty: Evaluation by Magnetic Resonance (SAVE-ME) study.
    Int J Cardiol. 2022;369:77-79.
    PubMed     Abstract available


  284. OPSTAL TSJ, Nidorf SM, Fiolet ATL, Eikelboom JW, et al
    Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
    Int J Cardiol. 2022 Dec 15:S0167-5273(22)01900.
    PubMed     Abstract available


  285. WANG C, Zhang M, Yan J, Wang R, et al
    Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction.
    Int J Cardiol. 2022 Dec 10:S0167-5273(22)01889.
    PubMed     Abstract available


  286. MORTBERG J, Salzinger B, Lundwall K, Edfors R, et al
    Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.
    Int J Cardiol. 2022 Dec 4:S0167-5273(22)01876.
    PubMed     Abstract available


  287. PENG YW, Major T, Deatrick KB, Mohammed A, et al
    Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass.
    Int J Cardiol. 2022;368:62-68.
    PubMed     Abstract available


  288. KAGEYAMA S, Serruys PW, Garg S, Ninomiya K, et al
    Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial.
    Int J Cardiol. 2022;368:28-38.
    PubMed     Abstract available


    November 2022
  289. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    PubMed     Abstract available


  290. DASA O, Pepine CJ, Pearson TA
    An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01723.
    PubMed    


  291. GROENLAND FTW, Huang J, Scoccia A, Neleman T, et al
    Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Int J Cardiol. 2022 Nov 24:S0167-5273(22)01730.
    PubMed     Abstract available


  292. GARCIA-GUIMARAES M, Sanz-Ruiz R, Sabate M, Velazquez-Martin M, et al
    Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?
    Int J Cardiol. 2022 Nov 23:S0167-5273(22)01720.
    PubMed     Abstract available


  293. YOON YH, Park GM, Lee JY, Lee JH, et al
    Relationship between sexual differences and cardiovascular risk factors in the prevalence of asymptomatic coronary disease.
    Int J Cardiol. 2022 Nov 19:S0167-5273(22)01709.
    PubMed     Abstract available


  294. JUNG C, Rezar R, Wischmann P, Masyuk M, et al
    The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.
    Int J Cardiol. 2022;367:1-10.
    PubMed     Abstract available


  295. GONZALEZ-DEL-HOYO M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, et al
    Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort.
    Int J Cardiol. 2022;367:90-98.
    PubMed     Abstract available


  296. HOLZKNECHT M, Lechner I, Reinstadler SJ
    The circadian clock in STEMI: A further contributor to the development of MVO?
    Int J Cardiol. 2022;367:115-116.
    PubMed    


  297. WANG J, Li Y, Zhang S
    N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;367:11-19.
    PubMed     Abstract available


  298. SIMSEK B, Jaffer FA, Kostantinis S, Karacsonyi J, et al
    Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2022;367:20-25.
    PubMed     Abstract available


  299. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    PubMed     Abstract available


  300. BOERHOUT CKM, de Waard GA, Lee JM, Mejia-Renteria H, et al
    Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry.
    Int J Cardiol. 2022 Nov 11:S0167-5273(22)01702.
    PubMed     Abstract available


  301. DE LUCA L, Rosato S, D'Errigo P, Giordani B, et al
    Covid-19 diagnosis and mortality in patients with non-ST-elevation myocardial infarction admitted in Italy during the national outbreak.
    Int J Cardiol. 2022 Nov 7. pii: S0167-5273(22)01695.
    PubMed     Abstract available


  302. PICA S, Crimi G, Castelvecchio S, Pazzanese V, et al
    Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01693.
    PubMed     Abstract available


  303. TORGUSON R, Mintz GS, Case BC, Di Mario C, et al
    Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
    Int J Cardiol. 2022;366:32-34.
    PubMed     Abstract available


    October 2022
  304. PARK HW, Ozcan I, Toya T, Ahmad A, et al
    Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Int J Cardiol. 2022 Oct 29. pii: S0167-5273(22)01670.
    PubMed     Abstract available


  305. TRAUB J, Schurmann P, Schmitt D, Gassenmaier T, et al
    Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01653.
    PubMed     Abstract available


  306. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    PubMed     Abstract available


  307. VANDENBRIELE C, Van Edom C, Tavazzi G
    Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach.
    Int J Cardiol. 2022 Oct 22. pii: S0167-5273(22)01649.
    PubMed     Abstract available


  308. RUSSO M, Jang IK
    Cholesterol crystals in atherosclerotic plaques: A future target to reduce the risk of plaque rupture?
    Int J Cardiol. 2022;365:30-31.
    PubMed    


  309. MORRONE D, Gentile F, Aimo A, Cameli M, et al
    Perspectives in noninvasive imaging for chronic coronary syndromes.
    Int J Cardiol. 2022;365:19-29.
    PubMed     Abstract available


  310. HONTON B, Lipiecki J, Monsegu J, Leroy F, et al
    Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
    Int J Cardiol. 2022;365:106-111.
    PubMed     Abstract available


  311. BEREZIN AE
    Signature of standard modifiable CV factors as unrecognizable risk factor of in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2022 Oct 7. pii: S0167-5273(22)01479.
    PubMed    


  312. FITZGERALD BT, Smith E, Scalia GM
    What are the prognostic implications and factors relating to exercise induced electrocardiographic ST segment changes in the setting of a non-ischemic stress echocardiogram?
    Int J Cardiol. 2022;364:157-161.
    PubMed     Abstract available


  313. QIN Z, Cao M, Xi X, Zhang Y, et al
    Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
    Int J Cardiol. 2022;364:162-168.
    PubMed     Abstract available


  314. COSENTINO N, Lucci C, Marenzi G
    Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
    Int J Cardiol. 2022;364:16-17.
    PubMed    


  315. YASUE H
    Coronary artery spasm: not rare but not fully understood yet.
    Int J Cardiol. 2022;364:18-19.
    PubMed    


  316. WANG J, Li C, Ding D, Zhang M, et al
    Functional comparison of different jailed balloon techniques in treating non-left main coronary bifurcation lesions.
    Int J Cardiol. 2022;364:20-26.
    PubMed     Abstract available


    September 2022
  317. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    PubMed     Abstract available


  318. DOMENICO T, Rita A, Giacomo S, Diego A, et al
    Salivary biomarkers for diagnosis of acute myocardial infarction: A systematic review.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01393.
    PubMed     Abstract available


  319. SAJID DS, Bokhari SFH
    Comment on "Single troponin measurement to rule-out acute myocardial infarction in early presenters".
    Int J Cardiol. 2022 Sep 21. pii: S0167-5273(22)01389.
    PubMed    


  320. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    PubMed     Abstract available


  321. DENNIS M, Howpage S, McGill M, Dutta S, et al
    Myocardial fibrosis in Type 2 Diabetes is associated with functional and metabolomic parameters.
    Int J Cardiol. 2022;363:179-184.
    PubMed     Abstract available


  322. DI FUSCO SA, Cianfrocca C, Bisceglia I, Spinelli A, et al
    Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease.
    Int J Cardiol. 2022;363:190-195.
    PubMed     Abstract available


  323. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    PubMed     Abstract available


  324. YAMAMOTO T, Ishii T, Ishida A
    Impact of post physiological assessment after treatment for de novo coronary lesions using drug-coated balloons.
    Int J Cardiol. 2022;363:11-19.
    PubMed     Abstract available


  325. LIN HC, Chou SH, Fan PC, Zhu Z, et al
    The association between Day-1 urine cadmium excretion and 30-day mortality in patients with acute myocardial infarction: A multi-institutional cohort study.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01321.
    PubMed     Abstract available


  326. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The perfect-CR study.
    Int J Cardiol. 2022 Sep 8. pii: S0167-5273(22)01322.
    PubMed     Abstract available


  327. SHARMA A, Gupta I, Venkatesh U, Singh AK, et al
    E-cigarettes and myocardial infarction: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Sep 7. pii: S0167-5273(22)01315.
    PubMed     Abstract available


  328. RAM P, Shah S, Patel B, Osman M, et al
    Outcomes among heart transplant recipients following acute coronary syndrome: A Nationwide population based study.
    Int J Cardiol. 2022 Sep 5. pii: S0167-5273(22)01267.
    PubMed     Abstract available


  329. WIENEMANN H, Ameskamp C, Mejia-Renteria H, Mauri V, et al
    Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions.
    Int J Cardiol. 2022;362:59-67.
    PubMed     Abstract available


  330. MATSUBAYASHI K, Soeda T
    Significance of superficial macrophage cluster in coronary atherosclerotic plaque.
    Int J Cardiol. 2022;362:24-25.
    PubMed    


  331. STATHOGIANNIS K, Fearon WF
    Untangling diffuse CAD: Light at the end of the tunnel?
    Int J Cardiol. 2022;362:20-21.
    PubMed    


  332. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.
    Int J Cardiol. 2022;362:42-46.
    PubMed     Abstract available


    August 2022
  333. DEMIRKIRAN A, van der Geest RJ, Hopman LHGA, Robbers LFHJ, et al
    Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling.
    Int J Cardiol. 2022 Aug 22. pii: S0167-5273(22)01250.
    PubMed     Abstract available


  334. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    PubMed     Abstract available


  335. STAHLI BE, Witassek FF, Roffi M, Eberli FR, et al
    Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
    Int J Cardiol. 2022 Aug 19. pii: S0167-5273(22)01200.
    PubMed    


  336. DE FILIPPO O, Russo C, Manai R, Borzillo I, et al
    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    Int J Cardiol. 2022 Aug 17. pii: S0167-5273(22)01201.
    PubMed     Abstract available


  337. MALHOTRA P, Han D
    Imaging tests for coronary artery disease risk assessment: Anatomy, physiology, or both?
    Int J Cardiol. 2022;361:124-125.
    PubMed    


  338. GAUTHIER V, Montaye M, Ferrieres J, Kai SHY, et al
    Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries.
    Int J Cardiol. 2022;361:103-108.
    PubMed     Abstract available


  339. GALLINORO E, Almendarez M, Alvarez-Velasco R, Barbato E, et al
    Bioresorbable stents: Is the game over?
    Int J Cardiol. 2022;361:20-28.
    PubMed     Abstract available


  340. MYHRE PL, Rosjo H, Sarvari SI, Ukkonen H, et al
    Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Int J Cardiol. 2022;361:14-17.
    PubMed     Abstract available


  341. TANG LH, Harrison A, Skou ST, Taylor RS, et al
    Are patient characteristics and modes of delivery associated with completion of cardiac rehabilitation? A national registry analysis.
    Int J Cardiol. 2022;361:7-13.
    PubMed     Abstract available


  342. MARBACH JA, Faugno AJ, Pacifici S, Chweich H, et al
    Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis.
    Int J Cardiol. 2022;361:77-84.
    PubMed     Abstract available


  343. LI Q, Xie E, Tu Y, Wu Y, et al
    Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2022 Aug 12. pii: S0167-5273(22)01193.
    PubMed     Abstract available


  344. CHEN Y, Wu J, Tang Y, Li Z, et al
    Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.
    Int J Cardiol. 2022 Aug 10. pii: S0167-5273(22)01189.
    PubMed     Abstract available


  345. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    PubMed     Abstract available


  346. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    PubMed     Abstract available


  347. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    PubMed     Abstract available


  348. HWANG R, Peters R, Harmer E, Boyde M, et al
    Insight into a real-world experience with completion of cardiac rehabilitation.
    Int J Cardiol. 2022;360:5-6.
    PubMed    


  349. GOEL V, Spear E, Cameron W, Thakur U, et al
    Breast arterial calcification and epicardial adipose tissue volume, but not density are independently associated with cardiovascular risk.
    Int J Cardiol. 2022;360:78-82.
    PubMed     Abstract available


  350. NAKAJIMA K, Yoshida S
    Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging.
    Int J Cardiol. 2022;360:101-103.
    PubMed    


  351. SEITZ A, Martinez Pereyra V, Hubert A, Klingel K, et al
    Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis.
    Int J Cardiol. 2022;360:1-4.
    PubMed     Abstract available


  352. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    PubMed     Abstract available


    July 2022
  353. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    PubMed     Abstract available


  354. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    PubMed     Abstract available


  355. SEITZ A, Martinez Pereyra V, Sechtem U, Ong P, et al
    Update on coronary artery spasm 2022 - A narrative review.
    Int J Cardiol. 2022;359:1-6.
    PubMed     Abstract available


  356. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    PubMed     Abstract available


  357. NELEMAN T, Scoccia A, Masdjedi K, Tomaniak M, et al
    The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study.
    Int J Cardiol. 2022;359:14-19.
    PubMed     Abstract available


  358. ZHANG L, Fu Z, Huang Y, Luo W, et al
    LOXL1-AS1 alleviates inflammatory response in the epicardial adipose tissue with coronary artery disease by sponging miR-3614.
    Int J Cardiol. 2022;359:113.
    PubMed    


  359. PRESCOTT E, Angeras O, Erlinge D, Grove EL, et al
    Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.
    Int J Cardiol. 2022 Jul 13. pii: S0167-5273(22)01084.
    PubMed     Abstract available


  360. BONFIG NL, Soukup CR, Shah AA, Davidson S, et al
    Circadian dependence of microvascular obstruction during ST-segment elevation myocardial infarction.
    Int J Cardiol. 2022 Jul 8. pii: S0167-5273(22)01036.
    PubMed     Abstract available


  361. MPLANI V, Apostolopoulos D, Koufou E, Spyridonidis T, et al
    Inferior myocardial wall ischemia on SPECT-MPI in patients with non dominant right coronary artery and non significant coronary artery disease.
    Int J Cardiol. 2022;358:8-10.
    PubMed     Abstract available


  362. XU JJ, Cui J, Lin Q, Chen XY, et al
    Response to "Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury".
    Int J Cardiol. 2022;358:11.
    PubMed    


  363. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    PubMed     Abstract available


  364. YU K, Yang C, Liu J, Mo D, et al
    GATA2 might be used to predict the susceptibility of people to coronary artery disease.
    Int J Cardiol. 2022;358:94.
    PubMed    


    June 2022
  365. ORBAN M, Kuehl A, Dischl D, Muller C, et al
    Fibrotic plaques in heart transplanted patients and their association with insulin resistance syndrome and Lp(a).
    Int J Cardiol. 2022 Jun 27. pii: S0167-5273(22)01015.
    PubMed     Abstract available


  366. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    PubMed     Abstract available


  367. YAN H, Zhao N, Geng W, Hou Z, et al
    Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions.
    Int J Cardiol. 2022;357:8-13.
    PubMed     Abstract available


  368. KIM HO, Jiang B, Poon EKW, Thondapu V, et al
    High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Int J Cardiol. 2022;357:1-7.
    PubMed     Abstract available


  369. HIGASHIOKA D, Shiono Y, Emori H, Khalifa AKM, et al
    Prevalence of myocardial perfusion scintigraphy derived ischemia in coronary lesions with discordant fractional flow reserve and non-hyperemic pressure ratios.
    Int J Cardiol. 2022;357:20-25.
    PubMed     Abstract available


  370. NGUYEN HL, Bui QT, Tran HV, Hoang MV, et al
    Characteristics, in-hospital management, and complications of acute myocardial infarction in northern and Central Vietnam.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00943.
    PubMed     Abstract available


  371. SUN M, Dube MP, Hennessy T, Schultz CJ, et al
    Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00926.
    PubMed     Abstract available


  372. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    PubMed     Abstract available


  373. CHOI YJ, Park MJ, Ko Y, Soh MS, et al
    Artificial intelligence versus physicians on interpretation of printed ECG images: Diagnostic performance of ST-elevation myocardial infarction on electrocardiography.
    Int J Cardiol. 2022 Jun 9. pii: S0167-5273(22)00869.
    PubMed     Abstract available


  374. MIR T, Uddin M, Changal K, Qureshi W, et al
    Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study.
    Int J Cardiol. 2022;356:6-11.
    PubMed     Abstract available


  375. ROONGSANGMANOON W, Wongsoasup A, Angkananard T, Rattanajaruskul N, et al
    Comparison of efficacy and safety of intracoronary nicardipine and adenosine for fractional flow reserve assessment of coronary stenosis.
    Int J Cardiol. 2022;356:1-5.
    PubMed     Abstract available


  376. KAVSAK PA, Mondoux SE, Ainsworth C, Worster A, et al
    High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
    Int J Cardiol. 2022;356:36-37.
    PubMed    


  377. AKIMARU K, Iwabuchi M, Ishida A, Uehara H, et al
    Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention.
    Int J Cardiol. 2022;356:30-35.
    PubMed     Abstract available


  378. SIMONI AH, Frydenlund J, Kragholm KH, Boggild H, et al
    Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: A systematic review.
    Int J Cardiol. 2022;356:19-29.
    PubMed     Abstract available


    May 2022
  379. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    PubMed     Abstract available


  380. PIVATO CA, Chandiramani R, Petrovic M, Nicolas J, et al
    Depression and ischemic heart disease.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00767.
    PubMed     Abstract available


  381. TRAVERSE JH
    When should patients with acute myocardial infarction undergo CABG? A question much in need of a randomized clinical trial?
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00768.
    PubMed    


  382. BERNARDI M, Spadafora L, Biondi-Zoccai G, Giordano A, et al
    Juvenile myocardial infarction: Sex matters.
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00757.
    PubMed    


  383. FLORIAN A
    Predicting LV thrombosis after acute myocardial infarction: From Virchow's triad to state-of-the-art cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2022 May 18. pii: S0167-5273(22)00745.
    PubMed    


  384. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.
    PubMed    


  385. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    PubMed     Abstract available


  386. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.
    PubMed    


  387. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    PubMed     Abstract available


  388. SVARTSTEIN AW, Lassen MH, Skaarup KG, Grove GL, et al
    Predictive value of left atrial strain in relation to atrial fibrillation following acute myocardial infarction.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00736.
    PubMed     Abstract available


  389. SHETTY MK, Kunal S, Girish MP, Qamar A, et al
    Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) Registry.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00734.
    PubMed     Abstract available


  390. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00660.
    PubMed     Abstract available


  391. IANNACCONE M, Franchin L, Hanson ID, Boccuzzi G, et al
    Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00662.
    PubMed     Abstract available


  392. MA F, Hao J, Zhao J, Liu DY, et al
    Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease.
    Int J Cardiol. 2022;354:50-55.
    PubMed     Abstract available


  393. GRAGNANO F, Cesaro A, Pelliccia F, Limongelli G, et al
    Early-onset MINOCA: Prognostic implications and considerations for practice.
    Int J Cardiol. 2022;354:14-16.
    PubMed    


  394. HITOMI Y, Masaki N, Ishinoda Y, Ido Y, et al
    Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality.
    Int J Cardiol. 2022;354:43-47.
    PubMed     Abstract available


  395. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2022;354:1-6.
    PubMed     Abstract available


    April 2022
  396. WANG Z, Li T, Li M, Gu W, et al
    MALAT1 aggravates cardiomyocytes injury in myocardial infarction by sponging miR-135b.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00636.
    PubMed    


  397. LI J, Chen R, Zhou J, Wang Y, et al
    The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00634.
    PubMed     Abstract available


  398. BENEDETTO U, Sinha S, Mulla A, Glampson B, et al
    Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study).
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00586.
    PubMed     Abstract available


  399. FERRELL MC, Elizabeth Garrett BA, Alicia Tomlin DO, Cole Wayant DO, et al
    Editorial conflicts of interest related to the Management of Stable Ischemic Heart Disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00569.
    PubMed     Abstract available


  400. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    PubMed     Abstract available


  401. CAO M, Luo H, Li D, Wang S, et al
    Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Int J Cardiol. 2022;353:109-117.
    PubMed     Abstract available


  402. SCICALI R
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease.
    Int J Cardiol. 2022;353:118.
    PubMed    


  403. ZHAO Z, Shi Q, Guo Q, Peng L, et al
    Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention.
    Int J Cardiol. 2022;353:3-8.
    PubMed     Abstract available


  404. D'ASCENZO F, Elia E, de Filippo O, Manai R, et al
    Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
    Int J Cardiol. 2022;353:9-14.
    PubMed     Abstract available


  405. NANDHAKUMAR V, Pakshirajan B, Chopra A, Anandan H, et al
    Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.
    Int J Cardiol. 2022;353:22-28.
    PubMed     Abstract available


  406. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    PubMed     Abstract available


  407. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    PubMed     Abstract available


  408. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed     Abstract available


  409. ONG P, Allgauer S
    Factors influencing medical care of STEMI patients during the COVID-19 pandemic worldwide.
    Int J Cardiol. 2022;352:195-196.
    PubMed    


  410. LV R, Wang L, Maehara A, Guo X, et al
    Image-based biomechanical modeling for coronary atherosclerotic plaque progression and vulnerability prediction.
    Int J Cardiol. 2022;352:1-8.
    PubMed     Abstract available


  411. VYNCKIER P, Kotseva K, Gevaert S, De Bacquer D, et al
    Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.
    Int J Cardiol. 2022;352:152-157.
    PubMed     Abstract available


  412. GALLINORO E, Monizzi G, Sonck J, Candreva A, et al
    Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy.
    Int J Cardiol. 2022;352:27-32.
    PubMed     Abstract available


  413. ZHANG D, Wu H, Liu D, Li Y, et al
    Targeting CRP in microvascular obstruction after PCI.
    Int J Cardiol. 2022;352:124.
    PubMed    


  414. ZHANG R, Xu B, Dou K, Guan C, et al
    Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality.
    Int J Cardiol. 2022;352:33-39.
    PubMed     Abstract available


  415. SCHAFER A
    Clopidogrel or ticagrelor in elderly patients with acute coronary syndromes - Nihil nocere!
    Int J Cardiol. 2022;352:19-20.
    PubMed    


  416. VAN BEEK KAJ, van Steenbergen GJ, Vervaat FE, Mulders BCJH, et al
    Single center experience in the treatment of hemodynamically significant diffuse coronary artery disease of the left anterior descending.
    Int J Cardiol. 2022;352:40-44.
    PubMed     Abstract available


  417. MASCI PG, Bogaert J
    Implementing the risk stratification in STEMI by cardiovascular magnetic resonance: An academic exercise or real benefit?
    Int J Cardiol. 2022;352:188-189.
    PubMed    


    March 2022
  418. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    PubMed     Abstract available


  419. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    PubMed    


  420. GONZALEZ FERRERO T, Alvarez Alvarez B, Cordero A, Martinon Martinez J, et al
    Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry.
    Int J Cardiol. 2022;351:8-14.
    PubMed     Abstract available


  421. DEMIRCI D, Demirci DE, Chi G
    Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study.
    Int J Cardiol. 2022;351:93-99.
    PubMed     Abstract available


  422. REINSTADLER SJ, Dlaska C, Reindl M, Marks M, et al
    Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00335.
    PubMed    


  423. BRUNO F, Moirano G, Budano C, Lalloni S, et al
    Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00331.
    PubMed     Abstract available


  424. CIFKOVA R
    Gender differences in secondary prevention of coronary heart disease: Far from closing the gap.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00322.
    PubMed    


  425. MONTINARI MR, Minelli P, Russo A, Gianicolo E, et al
    Patterns of coronary heart disease mortality in Italy from 1931 to 2015 and a focus on a region with highly industrialized areas.
    Int J Cardiol. 2022 Mar 9. pii: S0167-5273(22)00326.
    PubMed     Abstract available


  426. ZANCHIN C, Ledwoch S, Bar S, Ueki Y, et al
    Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.
    Int J Cardiol. 2022;350:1-8.
    PubMed     Abstract available


  427. PENG J, Xing CY, Zhao K, Deng J, et al
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease: A case-control study.
    Int J Cardiol. 2022;350:9-15.
    PubMed     Abstract available


  428. MATSUI S, Maruhashi T, Kishimoto S, Kajikawa M, et al
    Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study.
    Int J Cardiol. 2022;350:111-117.
    PubMed     Abstract available


  429. WU J, Huang Y, Zhang J, Xiang Z, et al
    LncRNA CPhar mediates exercise-induced cardioprotection by promoting eNOS phosphorylation at Ser1177 via DDX17/PI3K/Akt pathway after MI/RI.
    Int J Cardiol. 2022;350:16.
    PubMed    


    February 2022
  430. LU Y, Tian Y, Mou T, Zhou Y, et al
    Transient cardioprotective effects of remote ischemic postconditioning on non-reperfused myocardial infarction: longitudinal evaluation study in pigs.
    Int J Cardiol. 2022 Feb 18. pii: S0167-5273(22)00257.
    PubMed     Abstract available


  431. TILLER C, Reindl M, Reinstadler SJ, Klug G, et al
    The classical 12lead ECG: Much more to offer than just a diagnosis in STEMI?
    Int J Cardiol. 2022;349:29-30.
    PubMed    


  432. FUJISUE K, Yamamoto E, Sueta D, Takae M, et al
    Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome.
    Int J Cardiol. 2022;349:1-6.
    PubMed     Abstract available


  433. FERRO A
    Antithrombotic therapy after 1 year of dual antiplatelet therapy following acute coronary syndrome: What to do?
    Int J Cardiol. 2022;349:27-28.
    PubMed    


  434. SAITO Y, Saito Y, Kato K, Kobayashi Y, et al
    Gender differences in factors associated with vasospastic angina.
    Int J Cardiol. 2022;349:7-11.
    PubMed     Abstract available


  435. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    PubMed     Abstract available


  436. FAGA V, Anguera I, Oloriz T, Nombela-Franco L, et al
    Improved prediction of electrical storm in patients with prior myocardial infarction and implantable cardioverter defibrillator.
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00251.
    PubMed     Abstract available


  437. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    PubMed     Abstract available


  438. MARENGO G, De Filippo O, D'Ascenzo F, Iannaccone M, et al
    IVUS guided PCI in patients with acute myocardial infarction - The route toward a "plaque oriented" PCI.
    Int J Cardiol. 2022 Feb 11. pii: S0167-5273(22)00246.
    PubMed    


  439. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    PubMed    


  440. HOLZKNECHT M, Klug G, Metzler B, Reinstadler SJ, et al
    Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic.
    Int J Cardiol. 2022;348:23-25.
    PubMed    


  441. ASAKURA K, Minami Y, Kinoshita D, Katamine M, et al
    Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease.
    Int J Cardiol. 2022;348:134-139.
    PubMed     Abstract available


  442. XU X, Fam JM, Low AFH, Tan RS, et al
    Sex differences in assessing stenosis severity between physician visual assessment and quantitative coronary angiography.
    Int J Cardiol. 2022;348:9-14.
    PubMed     Abstract available


  443. ALFONSO F, Rivero F, Cortese B
    Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.
    Int J Cardiol. 2022;348:47-49.
    PubMed    


  444. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    PubMed     Abstract available


    January 2022
  445. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    PubMed     Abstract available


  446. GROENLAND FTW, Neleman T, Kakar H, Scoccia A, et al
    Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Jan 15. pii: S0167-5273(22)00068.
    PubMed     Abstract available


  447. ADLAM D, Zarebinski M, Uren NG, Ptaszynski P, et al
    A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Int J Cardiol. 2022;347:1-7.
    PubMed     Abstract available


  448. PERFETTI M, Di Nicola M, Zimarino M
    Asimmetric uncertainties and account balance. Editorial to "Instantaneous wave-free ratio compared with fractional flow 2 reserve in PCI: A cost-minimization analysis".
    Int J Cardiol. 2022;347:19-20.
    PubMed    


  449. KHAN E, Lambrakis K, Nazir SA, Chuang A, et al
    Implementation of more sensitive cardiac troponin T assay in a state-wide health service.
    Int J Cardiol. 2022;347:66-72.
    PubMed     Abstract available


  450. MA P, Liu J, Hu Y, Zhou X, et al
    Histologic validation of stress cardiac magnetic resonance T1-mapping techniques for detection of coronary microvascular dysfunction in rabbits.
    Int J Cardiol. 2022;347:76-82.
    PubMed     Abstract available


  451. GUECKEL J, Puelacher C, Glarner N, Gualandro DM, et al
    Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00062.
    PubMed     Abstract available


  452. WU Z, Cheng S, Wang S, Li W, et al
    C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expression.
    Int J Cardiol. 2022 Jan 8. pii: S0167-5273(22)00067.
    PubMed     Abstract available


  453. HU M, Lu Y, Wan S, Li B, et al
    Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00003.
    PubMed     Abstract available


  454. GIBSON CM, Mehta S, Ceschim MRS, Frauenfelder A, et al
    Evolution of single-lead ECG for STEMI detection using a deep learning approach.
    Int J Cardiol. 2022;346:47-52.
    PubMed     Abstract available


  455. FERRANNINI E, Marx N, Andreini D, Campi B, et al
    Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.
    Int J Cardiol. 2022;346:86-92.
    PubMed     Abstract available


  456. GATTO L, Alfonso F, Paoletti G, Burzotta F, et al
    Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study.
    Int J Cardiol. 2022;346:8-12.
    PubMed     Abstract available


    December 2021
  457. KUCHARSKA-NEWTON AM, Loop MS, Bullo M, Moore C, et al
    Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02014.
    PubMed     Abstract available


  458. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    PubMed     Abstract available


  459. ZEITZ C
    Relieving angina - interplay between gender, pathophysiology and medication efficacy.
    Int J Cardiol. 2021;345:20-21.
    PubMed    


  460. CESARO A, Gragnano F, Calabro P, Moscarella E, et al
    Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.
    Int J Cardiol. 2021;345:7-13.
    PubMed     Abstract available


  461. TAKAHASHI J, Shimokawa H, Yasuda S
    Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques.
    Int J Cardiol. 2021;345:24-25.
    PubMed    


  462. GALLI M, Franchi F
    Guided selection of antiplatelet therapy in acute coronary syndrome: Impact on outcomes and resource utilization.
    Int J Cardiol. 2021;345:36-38.
    PubMed    


  463. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70mg/dL vs. <55mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02012.
    PubMed     Abstract available


  464. MEHTA PK, Quesada O, Al-Badri A, Fleg J, et al
    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Int J Cardiol. 2021 Dec 10. pii: S0167-5273(21)02005.
    PubMed     Abstract available


  465. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    PubMed     Abstract available


  466. ANANTHAKRISHNA R, Liang Z, Raman B, Moran JL, et al
    Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01979.
    PubMed     Abstract available


  467. LEMESLE G, Bauters C, Bonello L, Fauchier L, et al
    Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01966.
    PubMed     Abstract available


  468. TSUJITA K
    Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
    Int J Cardiol. 2021;344:34-35.
    PubMed    


  469. BERNTORP K, Persson J, Koul SM, Patel MR, et al
    Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
    Int J Cardiol. 2021;344:54-59.
    PubMed     Abstract available


  470. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
    Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
    Int J Cardiol. 2021;344:1-7.
    PubMed     Abstract available


    November 2021
  471. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    PubMed     Abstract available


  472. MARCOS-GARCES V, Perez N, Gavara J, Lopez-Lereu MP, et al
    Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01866.
    PubMed     Abstract available


  473. GORIKI Y, Yoshioka G, Natsuaki M, Shinzato K, et al
    Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01862.
    PubMed     Abstract available


  474. HENG GE
    Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01853.
    PubMed    


  475. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    PubMed    


  476. TANG LH, Harrison A, Skou ST, Doherty P, et al
    To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
    Int J Cardiol. 2021;343:85-91.
    PubMed     Abstract available


  477. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
    Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2021;343:27-34.
    PubMed     Abstract available


  478. PYXARAS SA, Harmel EK
    Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
    Int J Cardiol. 2021;343:3-4.
    PubMed    


  479. FENDER AC, Dobrev D
    Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
    Int J Cardiol. 2021;343:102-103.
    PubMed    


  480. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
    Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
    Int J Cardiol. 2021;343:171-179.
    PubMed     Abstract available


  481. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
    Int J Cardiol. 2021;343:187-193.
    PubMed     Abstract available


  482. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    PubMed     Abstract available


  483. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    PubMed    


  484. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    PubMed     Abstract available


  485. XU JJ, Cui J, Lin Q, Chen XY, et al
    Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;342:82-93.
    PubMed     Abstract available


  486. TRAVERSE JH
    The coronary sinus reducer - Where modern technology meets old school physiology!
    Int J Cardiol. 2021;342:31-32.
    PubMed    


  487. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
    Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
    Int J Cardiol. 2021;342:7-14.
    PubMed     Abstract available


  488. LI KS, Bai Y, Li J, Li SL, et al
    LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
    Int J Cardiol. 2021;342:72-81.
    PubMed     Abstract available


    October 2021
  489. HAN X, Chen Z, Wang Y, Zhang J, et al
    Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Oct 26. pii: S0167-5273(21)01693.
    PubMed     Abstract available


  490. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    PubMed     Abstract available


  491. ONO M, Kawashima H, Hara H, Mancone M, et al
    Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
    Int J Cardiol. 2021;341:9-12.
    PubMed     Abstract available


  492. WEBB CM, Collins P
    Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
    Int J Cardiol. 2021;341:1-8.
    PubMed     Abstract available


  493. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
    Kounis syndrome: Towards a new classification.
    Int J Cardiol. 2021;341:13-14.
    PubMed    


  494. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.
    PubMed    


  495. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.
    PubMed    


  496. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    PubMed     Abstract available


  497. ARCHILLETTI F, Zimarino M
    Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
    Int J Cardiol. 2021;340:22-23.
    PubMed    


  498. GUO Y, Li Q, Xuan YT, Wu WJ, et al
    Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
    Int J Cardiol. 2021;340:68-78.
    PubMed     Abstract available


  499. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
    Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
    Int J Cardiol. 2021;340:7-13.
    PubMed     Abstract available


  500. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
    Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Int J Cardiol. 2021;340:17-21.
    PubMed     Abstract available


    September 2021
  501. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    PubMed    


  502. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
    Transient STEMI - No STEMI at all?
    Int J Cardiol. 2021;339:12-13.
    PubMed    


  503. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
    Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Int J Cardiol. 2021;339:28-32.
    PubMed     Abstract available


  504. LIU H, Bi K, Hu Y
    Targeting vimentin in coronary artery disease.
    Int J Cardiol. 2021;339:144.
    PubMed    


  505. JANG WJ, Park IH, Yang JH, Chun WJ, et al
    Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
    Int J Cardiol. 2021;339:70-74.
    PubMed     Abstract available


  506. ANGELINI P, Uribe C
    Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
    Int J Cardiol. 2021;339:45-46.
    PubMed    


  507. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
    Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Int J Cardiol. 2021;339:219-224.
    PubMed     Abstract available


    August 2021
  508. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    PubMed     Abstract available


    July 2021
  509. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.